Approval · Notice of Compliance 24277 · 2020
KANUMA: Notice of Compliance 24277
Issued September 21, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24277
- Date
- September 21, 2020
- Company
- Alexion Pharma GmbhBaar, --, Switzerland
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing facility
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KANUMA | Not yet assigned | — |
Medicinal ingredients
- SEBELIPASE ALFA 2 MG per ML